<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Yellow fever has also re‐emerged in the Democratic Republic of the Congo and Angola in 2015–16 and in Brazil in 2017–18. Theoretically, yellow fever should not be a problem, given the availability of an effective vaccine that provides lifelong immunity to infection. However, the recent epidemics in Africa and Brazil, combined with the limited number of vaccine manufacturers approved by WHO, significantly depleted the global stock of available vaccine. Surveillance should concentrate on urban areas and slums where 
 <italic class="italic">Ae. aegypti</italic>, the anthropophilic yellow fever mosquito, is present.
</p>
